These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 34925350

  • 1. Belimumab for Immune-Mediated Necrotizing Myopathy Associated With Anti-SRP Antibodies: A Case Report and Retrospective Review of Patients Treated With Anti-B-Cell Therapy in a Single Center and Literature.
    Cui BB, Tian YR, Ma XY, Yin G, Xie Q.
    Front Immunol; 2021; 12():777502. PubMed ID: 34925350
    [Abstract] [Full Text] [Related]

  • 2. Rituximab therapy for myopathy associated with anti-signal recognition particle antibodies: a case series.
    Valiyil R, Casciola-Rosen L, Hong G, Mammen A, Christopher-Stine L.
    Arthritis Care Res (Hoboken); 2010 Sep; 62(9):1328-34. PubMed ID: 20506493
    [Abstract] [Full Text] [Related]

  • 3. Immune-Mediated Necrotizing Myopathy.
    Pinal-Fernandez I, Casal-Dominguez M, Mammen AL.
    Curr Rheumatol Rep; 2018 Mar 26; 20(4):21. PubMed ID: 29582188
    [Abstract] [Full Text] [Related]

  • 4. Immunotherapy reversed myopathy but not cardiomyopathy in a necrotizing autoimmune myopathy patient with positive anti-SRP and MDA-5 autoantibodies.
    Ma X, Xu L, Li Y, Bu B.
    BMC Cardiovasc Disord; 2021 Feb 12; 21(1):88. PubMed ID: 33579193
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Immune-mediated necrotizing myopathy: clinical features and pathogenesis.
    Allenbach Y, Benveniste O, Stenzel W, Boyer O.
    Nat Rev Rheumatol; 2020 Dec 12; 16(12):689-701. PubMed ID: 33093664
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Anti-signal recognition particle positive necrotizing myopathy-sjogren's syndrome overlap syndrome: a descriptive study on clinical and myopathology features.
    Xu L, Yang MG, Hu L, Gao H, Ji S.
    BMC Musculoskelet Disord; 2023 Mar 23; 24(1):219. PubMed ID: 36959614
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Paraneoplastic Anti-3-hydroxy-3-methylglutary-coenzyme A Reductase Antibody-positive Immune-mediated Necrotizing Myopathy in a Patient with Uterine Cancer.
    Mizuma A, Kouchi M, Netsu S, Yutani S, Kitao R, Suzuki S, Murata K, Nagata E, Takizawa S.
    Intern Med; 2017 Mar 23; 56(14):1915-1918. PubMed ID: 28717093
    [Abstract] [Full Text] [Related]

  • 12. Immune-mediated necrotizing myopathy (IMNM): A myopathological challenge.
    Merlonghi G, Antonini G, Garibaldi M.
    Autoimmun Rev; 2022 Feb 23; 21(2):102993. PubMed ID: 34798316
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Influenza A (H3N2) infection followed by anti-signal recognition particle antibody-positive necrotizing myopathy: A case report.
    Iriki J, Yamamoto K, Senju H, Nagaoka A, Yoshida M, Iwasaki K, Ashizawa N, Hirayama T, Tashiro M, Takazono T, Imamura Y, Miyazaki T, Izumikawa K, Yanagihara K, Tsujino A, Fukuoka J, Uetani M, Satoh M, Mukae H.
    Int J Infect Dis; 2021 Feb 23; 103():33-36. PubMed ID: 33217572
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.